|
Gerald Chan, Sc.D. is Chairman and Chief Executive Officer of Morningside Ventures, with whom he has been associated since 1986. Prior to his career in technology, venture capital, and direct investment, both in the U.S. and China, Dr. Chan was a research fellow in pathology at the Harvard Medical School. He received his undergraduate training in engineering at the University of California, Los Angeles, and his Doctor of Science degree in Radiation Biology from Harvard University. Since 1986, he has been a board member of Hang Lung Development Company, Limited, of Hong Kong. Dr. Chan also serves on the board of a number of companies including Natural Polymer International Corporation. His many non-profit activities include serving on the Visiting Committee of the Harvard School of Public Health and on the Cancer Center of the Massachusetts General Hospital in Boston. | 